KOD peer analysis
Kodiak Sciences (KOD) against its competitors: price, today's move, 1-year return and market value side by side.
KOD and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BLCO Bausch + Lomb | $20.04 | 0.17% | 32.33% | – |
| BLTE Belite Bio | $154.11 | -0.41% | 57.09% | – |
| EYPT EyePoint | $0.38 | 7.89% | -96.92% | $30.04M |
| FDMT 4D Molecular | $11.35 | -4.62% | 0.27% | – |
| KPRX Kiora Pharmaceuticals | $1.56 | -11.36% | -38.34% | – |
| OCGN Ocugen | $0.73 | 3.40% | -50.91% | $238.29M |
| OCS Oculis | $8.26 | 0.24% | -58.89% | – |
| OCUL Ocular Therapeutix | $6.72 | -3.59% | -43.15% | $1.53B |
| OTLK Outlook Therapeutics | $0.47 | -5.15% | -62.25% | $113.96M |
| REGN Regeneron | $961.34 | 3.60% | 46.98% | $95.99B |
| KOD Kodiak Sciences | $97.53 | -1.66% | 363.33% | $6.23B |
- KOD's peers: BLCO (Bausch + Lomb), BLTE (Belite Bio), EYPT (EyePoint), FDMT (4D Molecular), KPRX (Kiora Pharmaceuticals), OCGN (Ocugen), OCS (Oculis), OCUL (Ocular Therapeutix).
Updated 2026-11-02 23:13 UTC